WAYNE, Pa.--(BUSINESS WIRE)--Trinseo (NYSE: TSE): Three Months Ended June 30, $millions, except per share data 2025 2024 Net Sales $ 784 $ 920 Net Loss (106) (68) Diluted EPS ($) (2.95) (1.92) Adjusted Net Loss* (76) (52) Adjusted EPS ($)* (2.12) (1.46) EBITDA* 26 64 Adjusted EBITDA* 42 67 *For a reconciliation of EBITDA, Adjusted EBITDA, and Adjusted Net Loss, all of which are non-GAAP measures, to Net Loss, as well as a reconcili
Related Questions
What is the outlook for revenue and profit in the remainder of 2025, and how does it align with management's guidance?
How does the decline in net sales and increase in net loss affect the company's cash flow and liquidity position?
What impact will the weakened financial performance have on the stock price and volatility in the short term?
How do Trinseo's Q2 2025 results compare to its main competitors in the specialty chemicals industry?
What are the key factors contributing to the increase in net loss and lower adjusted EPS?
How does the company's current debt level and leverage ratios compare to prior periods and industry peers?
What are the primary drivers behind the decline in net sales from $920M to $784M year-over-year?
What steps is management taking to address the decline in performance and improve margins?
How does the market's sentiment (+/-) and the -55 sentiment rating influence investor sentiment and short‑term trading strategies?
Are there any upcoming catalysts (e.g., product launches, regulatory approvals) that could affect the future outlook?
What is the outlook for the 2025 full-year earnings and cash flow guidance?
How does the current quarter's EBITDA of $26M compare to the company's historical EBITDA trends and guidance?
What are the implications of the adjusted versus GAAP metrics for assessing the company's underlying profitability?
Are there any specific operating segments or geographies driving the revenue decline?
Will the company consider any strategic actions such as asset sales, acquisitions, or cost-cutting initiatives to improve performance?